† Third-party testing indicates that devices with the Polar Ionization™ technology have proven effective at helping reduce Mold, Bacteria, PM2.5, SARS-CoV-2, E. Coli, MRSA, C. Difficil, VRE, TB (M Terrae), and more. These studies are often in controlled laboratory environments or through commercial 3rd party partners. Results will vary due to many real world variables including humidity, contamination concentrations and types, air flow, altitude, temperature, and more.
†Third-party testing indicates that devices that utilize the Air Oasis® AHPCO® catalyst PCO technology have proven effective at helping reduce, MERS CoV, TVOCs, Mold, Bacteria, Ammonia (NHS), Hydrogen Sulfide (HS2), Respiratory Suspended Particulates, Staphylococcus epidermidis, Aspergillus versicolor, Penicillium chrysogenum, E. Coli, Conidia and Hyphae from Alternaria, spores from Dreschlera, Cladosporium and Stachybotrys chartarum, and more. These studies are often in controlled laboratory environments or through commercial 3rd party partners. Results will vary due to many real world variables including humidity, contamination concentrations and types, air flow, altitude, temperature, and more.
†Coverage estimates are based primarily upon our 15 years of experience with clients and their real world environment and goals. Various lab, third party, and real world studies have shown varying speed and efficacy in different room types and sizes. Recommended coverages are for average contamination levels in residential spaces. Results will vary due to many real world variables including humidity, contamination concentrations and types, air flow, altitude, temperature, and more. Please contact us for free consultations regarding more specific recommendations and information: hypoair.com/consult
